Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01305109
Show Display Options
Rank Status Study
1 Unknown  A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E
Condition: Viral Gastroenteritis Due to Rotavirus
Interventions: Biological: ORV 116E;   Biological: Placebo

Indicates status has not been verified in more than two years